Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

SCAI: Model projects renal denervation’s benefits at 10 years

Renal denervation received a theoretical thumbs up at the Society of Cardiovascular Angiography and Interventions (SCAI) scientific sessions in Orlando, Fla., May 9, based on a model that predicts reduction in cardiovascular events in hypertensive patients treated with the ablation therapy. The projections need to be validated in clinical trials, the poster presenter cautioned.

Surgeon, hospital volume predict mortality in acute aortic dissection

Patients who undergo repair of acute aortic dissection by surgeons who average less than one case a year are almost twice as likely to die in the hospital than patients whose surgeons average five or more cases annually, according to an analysis published in the May issue of the Annals of Thoracic Surgery. Hospital volume also predicted mortality in the study.

Philips announces completion of enrollment in therapeutic hypothermia clinical study for heart attack patients

Royal Philips Electronics (NYSE: PHG, AEX: PHI), today announced the completion of patient enrollment in the CHILL-MI clinical study designed to further evaluate the safety and effectiveness of the company’s InnerCool RTx endovascular cooling system in patients with ST-elevation myocardial infarction (STEMI).  

NIH awards $40 million in grants to reduce stroke disparities in the US

Four research centers will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States. Together the centers are expected to receive $40 million in funding over five years, contingent on the availability of funds from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.

Stroke leaders: Retain payment for thrombectomy devices in select patients

Denying reimbursement for the use of thrombectomy devices in stroke patients who are ineligible for intravenous tissue-type plasminogen activator (t-PA) treatment would be unfair and may lead to poor outcomes, according to IMS III researchers.

ESC recommends patients and centres for renal denervation

Up to 10 per cent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including heart attacks. Clinical trials show that catheter-based renal denervation reduces blood pressure in patients who do not respond to conventional drug therapy.

Vascular Surgery Training: Options & Opportunities

No longer requiring certification in general surgery prior to certification in vascular surgery created several training pathways.

Cook recalls Zilver PTX Drug Eluting Peripheral Stent

Cook Medical is recalling its Zilver PTX Drug Eluting Peripheral Stent after receiving complaints about delivery system tip separation. Two adverse events, including one death, occurred in cases where a tip separation was reported.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.